Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Envoy Medical (COCH) Long-Term Debt Issuances (2022 - 2025)

Envoy Medical's Long-Term Debt Issuances history spans 4 years, with the latest figure at $5.0 million for Q2 2025.

On a quarterly basis, Long-Term Debt Issuances rose 100.0% to $5.0 million in Q2 2025 year-over-year; TTM through Dec 2025 was $10.0 million, a 50.0% decrease, with the full-year FY2025 number at $10.0 million, down 50.0% from a year prior.
Long-Term Debt Issuances hit $5.0 million in Q2 2025 for Envoy Medical, roughly flat from $5.0 million in the prior quarter.
Over the last five years, Long-Term Debt Issuances for COCH hit a ceiling of $7.5 million in Q3 2024 and a floor of $2.0 million in Q4 2022.
Historically, Long-Term Debt Issuances has averaged $4.2 million across 4 years, with a median of $4.5 million in 2023.
The widest YoY moves for Long-Term Debt Issuances: up 150.0% in 2024, down 16.67% in 2024.
Tracing COCH's Long-Term Debt Issuances over 4 years: stood at $2.0 million in 2022, then soared by 50.0% to $3.0 million in 2023, then surged by 66.67% to $5.0 million in 2024, then changed by 0.0% to $5.0 million in 2025.
Business Quant data shows Long-Term Debt Issuances for COCH at $5.0 million in Q2 2025, $5.0 million in Q1 2025, and $5.0 million in Q4 2024.